5-Nov-2024 5:59 AM CST - Business Wire Novanta Announces Financial Results for the Third Quarter 2024 Novanta Inc. (Nasdaq: NOVT) (Novanta or the Company), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the third quarter 2024. Financial Highlights Three Months Ended (In millions, except per share amounts) September 27, September 29, 2024 2023 GAAP Revenue $ 244.4 $ 221.5 Operating Income $ 32.6 $ 30.3 Net Income $ 19.2 $ 21.2 Diluted EPS
8-Oct-2024 4:00 PM CST - Business Wire Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, November 5, 2024 Novanta Inc. (Nasdaq: NOVT) (the Company), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its third quarter 2024 results on Tuesday, November 5, 2024. The Company will host a conference call on Tuesday, November 5, 2024, at 10:00 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the conference call can be accessed onli
5-Nov-2024 5:59 AM CST - Business Wire Novanta Announces Financial Results for the Third Quarter 2024 Novanta Inc. (Nasdaq: NOVT) (Novanta or the Company), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the third quarter 2024. Financial Highlights Three Months Ended (In millions, except per share amounts) September 27, September 29, 2024 2023 GAAP Revenue $ 244.4 $ 221.5 Operating Income $ 32.6 $ 30.3 Net Income $ 19.2 $ 21.2 Diluted EPS
8-Oct-2024 4:00 PM CST - Business Wire Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, November 5, 2024 Novanta Inc. (Nasdaq: NOVT) (the Company), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its third quarter 2024 results on Tuesday, November 5, 2024. The Company will host a conference call on Tuesday, November 5, 2024, at 10:00 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the conference call can be accessed onli
